Antigen Test for IDR 35 thousand, This is the Service Time at Gambir Station to Pasar Senen - News Liputan6.com

2022-05-29 06:56:41 By : Mr. Sino link

Liputan6.com, Jakarta - The Head of Public Relations of PT KAI Daop 1 Jakarta, Eva Chairunisa, stated that the tariff for the rapid antigen test at the station for train customers is Rp. 35,000."Starting January 1, 2022, Daop 1 Jakarta will apply a new tariff for the Rapid Test Antigen service at the station from Rp 45,000 to Rp 35,000," Eva said in a written statement, Saturday (1/1/2022).He explained that the requirements that must be completed for the antigen test are to show the ticket booking code.Eva also stated that the ticket fare will be returned 100 percent in cash if the test result is positive for Covid-19."In the area of ​​KAI Daop 1 Jakarta, since the beginning of the Nataru period, starting on December 17, 2021, until now, around 80,000 prospective train service users have used the antigen test service at the station," he said.The following are five stations that serve antigen rapid test in the Daop 1 area of ​​Jakarta:- Pasar Senen Station: 05.00-22.30 WIBWhat is the difference between Rapid Antibody Test, Antigen Rapid Test, and PCR?Come on, check out the video above!Previously, PT Kereta Api Indonesia (Persero) or PT KAI cut the tariff for the Rapid Test Antigen service at the station to Rp 35 thousand from the previous Rp 45 thousand.There are 83 stations in Indonesia that will provide this Antigen Rapid Test service.PT KAI's VP of Public Relations Joni Martinus explained, the reduction in the Rapid Test Antigen rate was a form of improving KAI's services to customers during the 2022 New Year holiday."This new tariff is effective from January 1, 2022 at 83 stations that serve the Antigen Rapid Test," said Joni Martinus, in an official statement, Thursday (12/30/2021).The presence of the Rapid Test Antigen service at the station is the result of SOE synergy between KAI and Rajawali Nusantara Indonesia through its subsidiary, Rajawali Nusindo, Indofarma through its subsidiary, Farmalab, and other parties.